Discover

CTXR
Citius Pharmaceuticals, Inc.
0.61
2 x 0.44
2 x 0.76
bid
ask
+
0.00
0.73%
2 @ 04:00 PM
0.61 +0.00 (0.18%)
Ytd-21.63%
1y-67.95%
0.58
day range
0.63
0.48
52 week range
2.48
Open0.58Prev Close0.60Low0.58High0.63Mkt Cap16.72M
Vol337.63KAvg Vol631.68KEPS-2.14P/EN/AForward P/E15.32
Beta1.66Short Ratio1.23Inst. Own13.17%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1450-d Avg0.63200-d Avg0.931yr Est54.00

CTXR News

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

benzinga.com
Citius Oncology Presents Phase 1 Clinical Data Of LYMPHIR In Combination With Pembrolizumab In Pati

Citius Oncology, Inc. ("Citius Oncology") (NASDAQ:CTOR), an oncology‑focused biopharmaceutic

benzinga.com
HC Wainwright & Co. Assumes Citius Pharmaceuticals at Buy, Announces Price Target of $4

HC Wainwright & Co. analyst Swayampakula Ramakanth assumes Citius Pharmaceuticals (NASDAQ:CTX

12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

benzinga.com
UPDATE: Reported Earlier, Citius Pharma Prices $5M Offering Of 5,076,143 Shares At A Price Of $0.985

Citius Pharmaceuticals Inc. (NASDAQ:CTXR) ("Citius Pharma" or the "Company"), a biop

What's Behind The Drop In Citius Pharmaceuticals?
benzinga.com
What's Behind The Drop In Citius Pharmaceuticals?

Citius Pharmaceuticals (NASDAQ:CTXR) shares tumbled on Friday after it announced a registered direct

12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

benzinga.com
Citius Oncology Provides Commercial Update On U.S. Launch Of LYMPHIR For Treatment Of CTCL, Highligh

Broad institutional uptake among leading cancer centers and payer coverage supports early prescribin

benzinga.com
Citius Oncology Announces Data From Phase 1 Clinical Study Of Direct T-Regulatory Cell Depletion Act

Citius Oncology, Inc. ("Citius Oncology") (NASDAQ:CTOR), an oncology‑focused biopharmaceutic

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

benzinga.com
Citius Oncology Announces Topline Results From Investigator‑Initiated Phase 1 Trial Of LYMPHIR Admin

Topline data of investigator‑initiated study at the University of Minnesota and City of Hope demonst

Citius Pharmaceuticals Q1 Earnings Report: What Investors Need to Know
benzinga.com
Citius Pharmaceuticals Q1 Earnings Report: What Investors Need to Know

benzinga.com
Citius Pharma Q1 EPS $(0.38) Misses $(0.30) Estimate, Sales $3.944M Beat $3.455M Estimate

Citius Pharma (NASDAQ:CTXR) reported quarterly losses of $(0.38) per share which missed the analyst

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

benzinga.com
Gold Edges Lower; Omeros Shares Jump

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

Dow Gains Over 100 Points; US Jobless Claims Decline
benzinga.com
Dow Gains Over 100 Points; US Jobless Claims Decline

Stock Market Today: Dow Jones, Nasdaq Futures Slip On Christmas Eve Despite Strong Q3 GDP Report— UiPath, AST SpaceMobile, Ramaco In Focus (UPDATED)
benzinga.com
Stock Market Today: Dow Jones, Nasdaq Futures Slip On Christmas Eve Despite Strong Q3 GDP Report— Ui

(Editor’s note: The future prices of benchmark tracking ETFs and headline were updated in the story.

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Citius Pharmaceuticals (CTXR) Surges 22% After Hours — Here's Why
benzinga.com
Citius Pharmaceuticals (CTXR) Surges 22% After Hours — Here's Why

Citius Pharmaceuticals shares jumped 22.12% after hours following the commercial launch of its LYMPH

UiPath, Ramaco Resources And 3 Stocks To Watch Heading Into Wednesday
benzinga.com
UiPath, Ramaco Resources And 3 Stocks To Watch Heading Into Wednesday

U.S. stock futures slightly lower. UiPath joins S&P Midcap 400, Agios receives FDA approval, Can

benzinga.com
Citius Pharma Q4 EPS $(0.11) Beats $(0.43) Estimate

Citius Pharma (NASDAQ:CTXR) reported quarterly losses of $(0.11) per share which beat the analyst co

benzinga.com
Citius Pharmaceuticals' Subsidiary Citius Oncology Launches Cancer Immunotherapy, LYMPHIR, In The U.

Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (NASDAQ: CTXR), a bi

benzinga.com
D. Boral Capital Maintains Buy on Citius Pharmaceuticals, Maintains $6 Price Target

D. Boral Capital analyst Jason Kolbert maintains Citius Pharmaceuticals (NASDAQ:CTXR) with a Buy

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

benzinga.com
Citius Pharma Subsidiary Announces Commercial Launch Of LYMPHIR, IL-2 Receptor-Directed Fusion Prote

Citius Oncology, Inc. ("Citius Oncology") (NASDAQ:CTOR), the oncology-focused subsidiary of

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

PACCAR Posts Downbeat Earnings, Joins Neuphoria Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
benzinga.com
PACCAR Posts Downbeat Earnings, Joins Neuphoria Therapeutics, Citius Pharmaceuticals And Other Big S

benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

benzinga.com
Citius Oncology Secures McKesson As Authorized U.S. Distributor For LYMPHIR Ahead Of Q4 2025 Launch

McKesson joins leading distribution service providers as authorized U.S. distributor of LYMPHIRCRANF

benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

Why Casey's General Stores Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Casey's General Stores Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premar

benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

This Deckers Outdoor Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
benzinga.com
This Deckers Outdoor Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session

benzinga.com
Why Vincerx Pharma Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket

benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 386 stocks made new 52-week lows.

benzinga.com
Why Apellis Pharmaceuticals Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In

Gainers Yellow Corporation (NASDAQ: YELL) shares jumped 106% to $1.46. The trucking company cease

benzinga.com
CSX, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Friday's Pre-Market Session

U.S. stock futures traded mixed this morning on Monday. Here are some big stocks recording losses in

benzinga.com
Why FreightCar America Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket

Gainers Biodexa Pharmaceuticals (NASDAQ: BDRX) shares rose 76% to $0.8276 in pre-market trading a

benzinga.com
Why Ontrak Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Wednesday's Mid-D

Gainers Ontrak, Inc. (NASDAQ: OTRK) shares jumped 101.7% to $1.1599 after the company announced n